Virginia Retirement Systems Et Al Arcus Biosciences, Inc. Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 25,000 shares of RCUS stock, worth $393,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 40,200
37.81%
Holding current value
$393,000
Previous $816,000
45.1%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RCUS
# of Institutions
207Shares Held
49MCall Options Held
173KPut Options Held
151K-
Black Rock Inc. New York, NY9.76MShares$153 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$82.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.25MShares$66.7 Million0.65% of portfolio
-
State Street Corp Boston, MA3.06MShares$48 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.83MShares$28.8 Million0.08% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.13B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...